{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T17:43:56Z","timestamp":1792691036147,"version":"4.5.0"},"reference-count":39,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T00:00:00Z","timestamp":1789689600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Microbiol."],"abstract":"<jats:p>Variants of the SARS-CoV-2 virus continue to evolve. Rapidly emerging mutations, particularly in the Spike glycoprotein, may increase transmissibility and infectivity, and also lead to evasion of the immune response. The Spike protein contains two immunodominant epitopes: NTD and RBD. Numerous neutralizing antibodies against NTD are found in patient sera, and most of these target \u201csupersite\u201d epitopes. Consequently, mutations outside this region receive less attention. Our work continues the investigation of the effect of insertions outside the \u201csupersite\u201d on the phenotypic properties of SARS-CoV-2. Previously we characterized two closely related SARS-CoV-2 Delta variants differing by a 12-nucleotide insertion in the N-terminal domain of the Spike glycoprotein. In the present study, we modeled these two Spike glycoproteins and used them to perform spatial alignment analyses of S-protein structures in complex with antibodies against the NTD to assess the potential impact of the insertion on virus binding by neutralizing antibodies. We identified four potential scenarios, how the insertion can impact the binding of neutralizing antibodies targeting the NTD. Our study confirms the importance of investigating rapidly emerging mutations in the NTD, not only within the \u201csupersite\u201d but also beyond it. These mutations may contribute to immune evasion; consequently, their investigation is crucial for assessing the efficacy of commercially available monoclonal antibodies and vaccine preparations.<\/jats:p>","DOI":"10.3389\/fmicb.2026.1912073","type":"journal-article","created":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T05:39:18Z","timestamp":1789709958000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Insertion outside the supersite in the N-terminal domain of the SARS-CoV-2 spike glycoprotein may contribute to evasion of neutralizing antibodies"],"prefix":"10.3389","volume":"17","author":[{"given":"Elena A.","family":"Ermolaeva","sequence":"first","affiliation":[{"name":"Laboratory of Biochemistry, Chumakov FSC R&D IBP RAS\/Institute of Poliomyelitis","place":["Moscow, Russia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anastasia D.","family":"Fomina","sequence":"additional","affiliation":[{"name":"Laboratory of Antivirals, Chumakov FSC R&D IBP RAS\/Institute of Poliomyelitis","place":["Moscow, Russia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna N.","family":"Zyrina","sequence":"additional","affiliation":[{"name":"Laboratory of Biochemistry, Chumakov FSC R&D IBP RAS\/Institute of Poliomyelitis","place":["Moscow, Russia"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,9,18]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"e2304667120","DOI":"10.1073\/pnas.2304667120","article-title":"High-resolution mapping reveals the mechanism and contribution of genome insertions and deletions to RNA virus evolution","volume":"120","author":"Aguilar Rangel","year":"2023","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"B2","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1093\/nar\/28.1.235","article-title":"The protein data bank","volume":"28","author":"Berman","year":"2000","journal-title":"Nucleic Acids Res."},{"key":"B3","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1007\/82_2015_483","article-title":"\u201cFidelity Variants and RNA Quasispecies,\u201d","author":"Border\u00eda","year":"2015","journal-title":"Quasispecies: From Theory to Experimental Systems"},{"key":"B4","doi-asserted-by":"publisher","first-page":"1421","DOI":"10.1038\/s41467-023-36745-0","article-title":"Structural dynamics in the evolution of SARS-CoV-2 spike glycoprotein","volume":"14","author":"Calvaresi","year":"2023","journal-title":"Nat. Commun."},{"key":"B5","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1186\/1471-2105-10-421","article-title":"BLAST+: architecture and applications","volume":"10","author":"Camacho","year":"2009","journal-title":"BMC Bioinform."},{"key":"B6","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1016\/j.chom.2021.03.005","article-title":"Potent SARS-CoV-2 neutralizing antibodies directed against spike N-terminal domain target a single supersite","volume":"29","author":"Cerutti","year":"2021","journal-title":"Cell Host Microbe."},{"key":"B7","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1126\/science.abc6952","article-title":"A neutralizing human antibody binds to the N-terminal domain of the spike protein of SARS-CoV-2","volume":"369","author":"Chi","year":"2020","journal-title":"Science."},{"key":"B8","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1016\/j.cell.2022.01.019","article-title":"Structural and functional characterizations of infectivity and immune evasion of SARS-CoV-2 Omicron","volume":"185","author":"Cui","year":"2022","journal-title":"Cell"},{"key":"B9","doi-asserted-by":"publisher","first-page":"e01511","DOI":"10.1128\/jvi.01511-23","article-title":"Puzzles, challenges, and information reservoir of SARS-CoV-2 quasispecies","volume":"97","author":"Domingo","year":"2023","journal-title":"J. Virol."},{"key":"B10","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1016\/B978-0-12-800049-6.00239-0","article-title":"\u201cSpecies Concepts: Viral Quasispecies,\u201d","author":"Domingo","year":"2016","journal-title":"Encyclopedia of Evolutionary Biology"},{"key":"B11","doi-asserted-by":"publisher","first-page":"1792","DOI":"10.1093\/nar\/gkh340","article-title":"MUSCLE: multiple sequence alignment with high accuracy and high throughput","volume":"32","author":"Edgar","year":"2004","journal-title":"Nucleic Acids Res."},{"key":"B12","doi-asserted-by":"publisher","first-page":"277","DOI":"10.3390\/v18030277","article-title":"Insertion in the N-terminal domain of the SARS-CoV-2 spike glycoprotein affects antibody recognition and phenotypic properties","volume":"18","author":"Ermolaeva","year":"2026","journal-title":"Viruses"},{"key":"B13","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1038\/s41579-021-00573-0","article-title":"SARS-CoV-2 variants, spike mutations and immune escape","volume":"19","author":"Harvey","year":"2021","journal-title":"Nat. Rev. Microbiol."},{"key":"B14","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1007\/s15010-024-02223-y","article-title":"SARS-CoV-2 journey: from alpha variant to omicron and its sub-variants","volume":"52","author":"Hattab","year":"2024","journal-title":"Infection"},{"key":"B15","doi-asserted-by":"publisher","first-page":"5556","DOI":"10.1016\/j.csbj.2021.10.004","article-title":"N-terminal domain mutations of the spike protein are structurally implicated in epitope recognition in emerging SARS-CoV-2 strains","volume":"19","author":"Klinakis","year":"2021","journal-title":"Comput. Struct. Biotechnol. J."},{"key":"B16","doi-asserted-by":"publisher","first-page":"2114","DOI":"10.3390\/v13112114","article-title":"Mutational hotspot in the SARS-CoV-2 spike protein N-terminal domain conferring immune escape potential","volume":"13","author":"Kubik","year":"2021","journal-title":"Viruses"},{"key":"B17","doi-asserted-by":"publisher","first-page":"1547","DOI":"10.1093\/molbev\/msy096","article-title":"MEGA X: molecular evolutionary genetics analysis across computing platforms","volume":"35","author":"Kumar","year":"2018","journal-title":"Mol. Biol. Evol."},{"key":"B18","doi-asserted-by":"publisher","first-page":"e1001005","DOI":"10.1371\/journal.ppat.1001005","article-title":"Quasispecies theory and the behavior of RNA viruses","volume":"6","author":"Lauring","year":"2010","journal-title":"PLoS Pathog."},{"key":"B19","doi-asserted-by":"publisher","first-page":"e00242","DOI":"10.1128\/jvi.00242-25","article-title":"Role of glycosylation mutations at the N-terminal domain of SARS-CoV-2 XEC variant in immune evasion, cell-cell fusion, and spike stability","volume":"99","author":"Li","year":"2025","journal-title":"J. Virol."},{"key":"B20","doi-asserted-by":"publisher","first-page":"2442","DOI":"10.1016\/j.immuni.2023.09.003","article-title":"Antibodies targeting a quaternary site on SARS-CoV-2 spike glycoprotein prevent viral receptor engagement by conformational locking","volume":"56","author":"Liu","year":"2023","journal-title":"Immunity"},{"key":"B21","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1038\/s41586-020-2571-7","article-title":"Potent neutralizing antibodies against multiple epitopes on SARS-CoV-2 spike","volume":"584","author":"Liu","year":"2020","journal-title":"Nature"},{"key":"B22","doi-asserted-by":"publisher","first-page":"2421","DOI":"10.3390\/v15122421","article-title":"Enhancement of SARS-CoV-2 Infection via Crosslinking of Adjacent Spike Proteins by N-Terminal Domain-Targeting Antibodies","volume":"15","author":"Lusiany","year":"2023","journal-title":"Viruses"},{"key":"B23","doi-asserted-by":"publisher","first-page":"2332","DOI":"10.1016\/j.cell.2021.03.028","article-title":"N-terminal domain antigenic mapping reveals a site of vulnerability for SARS-CoV-2","volume":"184","author":"McCallum","year":"2021","journal-title":"Cell"},{"key":"B24","doi-asserted-by":"publisher","first-page":"e4792","DOI":"10.1002\/pro.4792","article-title":"UCSF ChimeraX : tools for structure building and analysis","volume":"32","author":"Meng","year":"2023","journal-title":"Protein Sci."},{"key":"B25","doi-asserted-by":"publisher","first-page":"106256","DOI":"10.1016\/j.isci.2023.106256","article-title":"Incorporation of SARS-CoV-2 spike NTD to RBD protein vaccine improves immunity against viral variants","volume":"26","author":"Montgomerie","year":"2023","journal-title":"iScience"},{"key":"B26","doi-asserted-by":"publisher","first-page":"msag100","DOI":"10.1093\/molbev\/msag100","article-title":"Epistasis and background dependence in the evolution of Omicron variants of the SARS-CoV-2 spike protein","volume":"43","author":"Moulana","year":"2026","journal-title":"Mol. Biol. Evol."},{"key":"B27","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1038\/s41586-023-06599-z","article-title":"Sialoglycan binding triggers spike opening in a human coronavirus","volume":"624","author":"Pronker","year":"2023","journal-title":"Nature"},{"key":"B28","doi-asserted-by":"publisher","first-page":"e108944","DOI":"10.15252\/embj.2021108944","article-title":"SARS-CoV-2 Alpha, Beta, and Delta variants display enhanced spike-mediated syncytia formation","volume":"40","author":"Rajah","year":"2021","journal-title":"EMBO J."},{"key":"B29","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1016\/S0168-9525(00)02024-2","article-title":"EMBOSS: the European molecular biology open software suite","volume":"16","author":"Rice","year":"2000","journal-title":"Trends Genet."},{"key":"B30","doi-asserted-by":"publisher","first-page":"eabg7607","DOI":"10.1126\/sciadv.abg7607","article-title":"SARS-CoV-2 can recruit a heme metabolite to evade antibody immunity","volume":"7","author":"Rosa","year":"2021","journal-title":"Sci. Adv."},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1159\/000542164","article-title":"SARS-CoV-2 Infection and the neuroendocrine system","author":"Sasikumar","year":"2024","journal-title":"Neuroendocrinology"},{"key":"B32","doi-asserted-by":"publisher","first-page":"e178880","DOI":"10.1172\/JCI178880","article-title":"Structural characterization of human monoclonal antibodies targeting uncommon antigenic sites on spike glycoprotein of SARS-CoV","volume":"135","author":"Suryadevara","year":"2025","journal-title":"J. Clin. Invest."},{"key":"B33","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1038\/s41579-020-00468-6","article-title":"Coronavirus biology and replication: implications for SARS-CoV-2","volume":"19","author":"V'kovski","year":"2021","journal-title":"Nat. Rev. Microbiol."},{"key":"B34","doi-asserted-by":"publisher","first-page":"1108","DOI":"10.1126\/science.abg5268","article-title":"Prevalent, protective, and convergent IgG recognition of SARS-CoV-2 non-RBD spike epitopes","volume":"372","author":"Voss","year":"2021","journal-title":"Science."},{"key":"B35","doi-asserted-by":"publisher","first-page":"1611","DOI":"10.1016\/j.immuni.2021.06.003","article-title":"Analysis of SARS-CoV-2 variant mutations reveals neutralization escape mechanisms and the ability to use ACE2 receptors from additional species","volume":"54","author":"Wang","year":"2021","journal-title":"Immunity"},{"key":"B36","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1002\/cpbi.3","article-title":"Comparative protein structure modeling using MODELLER","volume":"54","author":"Webb","year":"2016","journal-title":"CP Bioinform."},{"key":"B37","doi-asserted-by":"publisher","first-page":"W407","DOI":"10.1093\/nar\/gkm290","article-title":"ProSA-web: interactive web service for the recognition of errors in three-dimensional structures of proteins","volume":"35","author":"Wiederstein","year":"2007","journal-title":"Nucleic Acids Res."},{"key":"B38","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/j.coviro.2021.08.010","article-title":"Structure of SARS-CoV-2 spike protein","volume":"50","author":"Zhang","year":"2021","journal-title":"Curr. Opin. Virol."},{"key":"B39","doi-asserted-by":"publisher","first-page":"e70008","DOI":"10.1002\/mco2.70008","article-title":"Defining the features and structure of neutralizing antibody targeting the silent face of the SARS-CoV-2 spike N-terminal domain","volume":"5","author":"Zhang","year":"2024","journal-title":"MedComm."}],"updated-by":[{"DOI":"10.3389\/fmicb.2026.2018773","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T00:00:00Z","timestamp":1792627200000}}],"container-title":["Frontiers in Microbiology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmicb.2026.1912073\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T16:51:08Z","timestamp":1792687868000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmicb.2026.1912073\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,18]]},"references-count":39,"alternative-id":["10.3389\/fmicb.2026.1912073"],"URL":"https:\/\/doi.org\/10.3389\/fmicb.2026.1912073","relation":{},"ISSN":["1664-302X"],"issn-type":[{"value":"1664-302X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,18]]},"article-number":"1912073"}}